Since our world is changing rapidly, especially biotech and healthcare fields must actively adapt to those alterations. We can all learn from leaders in other industries to understand how our organizations and lives may be changed in the following years.
For the past 25 years, the Alliance of CEOs has brought leaders together, and their collective innovations are now transforming every aspect of our lives. This is the first of a series of virtual Alliance of CEOs Roundtables with Visionary Leaders when we discuss the Future of Health&Healthcare.
Breast cancer (BC) constitutes the most common female malignancy and nowadays molecular classification of subtypes is crucial to estimate a patient’s prognosis and administer appropriate treatment. It allows tailoring therapeutic strategy much more precisely than using a standalone IHC status.
